Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Expression and modulation of S100A4 protein by human mast cells.

Domenis R, Pilutti D, Orsaria M, Marzinotto S, Candotti V, Bosisio G, Bulfoni M, Ruaro ME, Di Loreto C, Mea VD, Toffoletti E, Londero AP, Mariuzzi L, Gri G.

Cell Immunol. 2018 Oct;332:85-93. doi: 10.1016/j.cellimm.2018.08.001. Epub 2018 Aug 4.

PMID:
30097176
2.

Systemic T Cells Immunosuppression of Glioma Stem Cell-Derived Exosomes Is Mediated by Monocytic Myeloid-Derived Suppressor Cells.

Domenis R, Cesselli D, Toffoletto B, Bourkoula E, Caponnetto F, Manini I, Beltrami AP, Ius T, Skrap M, Di Loreto C, Gri G.

PLoS One. 2017 Jan 20;12(1):e0169932. doi: 10.1371/journal.pone.0169932. eCollection 2017.

3.

Functional expression of aryl hydrocarbon receptor on mast cells populating human endometriotic tissues.

Mariuzzi L, Domenis R, Orsaria M, Marzinotto S, Londero AP, Bulfoni M, Candotti V, Zanello A, Ballico M, Mimmi MC, Calcagno A, Marchesoni D, Di Loreto C, Beltrami AP, Cesselli D, Gri G.

Lab Invest. 2016 Sep;96(9):959-971. doi: 10.1038/labinvest.2016.74. Epub 2016 Jun 27.

4.

Mast cells contribute to autoimmune diabetes by releasing interleukin-6 and failing to acquire a tolerogenic IL-10+ phenotype.

Betto E, Usuelli V, Mandelli A, Badami E, Sorini C, Capolla S, Danelli L, Frossi B, Guarnotta C, Ingrao S, Tripodo C, Pucillo C, Gri G, Falcone M.

Clin Immunol. 2017 May;178:29-38. doi: 10.1016/j.clim.2015.12.013. Epub 2015 Dec 28.

PMID:
26732858
5.

Mast cells boost myeloid-derived suppressor cell activity and contribute to the development of tumor-favoring microenvironment.

Danelli L, Frossi B, Gri G, Mion F, Guarnotta C, Bongiovanni L, Tripodo C, Mariuzzi L, Marzinotto S, Rigoni A, Blank U, Colombo MP, Pucillo CE.

Cancer Immunol Res. 2015 Jan;3(1):85-95. doi: 10.1158/2326-6066.CIR-14-0102. Epub 2014 Oct 28.

6.

A novel method to generate and culture human mast cells: Peripheral CD34+ stem cell-derived mast cells (PSCMCs).

Schmetzer O, Valentin P, Smorodchenko A, Domenis R, Gri G, Siebenhaar F, Metz M, Maurer M.

J Immunol Methods. 2014 Nov;413:62-8. doi: 10.1016/j.jim.2014.07.003. Epub 2014 Jul 17.

PMID:
25038510
7.

Allergic responses and aryl hydrocarbon receptor novel pathway of mast cell activation.

Sibilano R, Pucillo CE, Gri G.

Mol Immunol. 2015 Jan;63(1):69-73. doi: 10.1016/j.molimm.2014.02.015. Epub 2014 Mar 18. Review.

PMID:
24656327
8.

Glioma-associated stem cells: a novel class of tumor-supporting cells able to predict prognosis of human low-grade gliomas.

Bourkoula E, Mangoni D, Ius T, Pucer A, Isola M, Musiello D, Marzinotto S, Toffoletto B, Sorrentino M, Palma A, Caponnetto F, Gregoraci G, Vindigni M, Pizzolitto S, Falconieri G, De Maglio G, Pecile V, Ruaro ME, Gri G, Parisse P, Casalis L, Scoles G, Skrap M, Beltrami CA, Beltrami AP, Cesselli D.

Stem Cells. 2014 May;32(5):1239-53. doi: 10.1002/stem.1605.

9.

Mast cell: an emerging partner in immune interaction.

Gri G, Frossi B, D'Inca F, Danelli L, Betto E, Mion F, Sibilano R, Pucillo C.

Front Immunol. 2012 May 25;3:120. doi: 10.3389/fimmu.2012.00120. eCollection 2012.

10.

The aryl hydrocarbon receptor modulates acute and late mast cell responses.

Sibilano R, Frossi B, Calvaruso M, Danelli L, Betto E, Dall'Agnese A, Tripodo C, Colombo MP, Pucillo CE, Gri G.

J Immunol. 2012 Jul 1;189(1):120-7. doi: 10.4049/jimmunol.1200009. Epub 2012 May 30.

11.

Modulation of FcεRI-dependent mast cell response by OX40L via Fyn, PI3K, and RhoA.

Sibilano R, Frossi B, Suzuki R, D'Incà F, Gri G, Piconese S, Colombo MP, Rivera J, Pucillo CE.

J Allergy Clin Immunol. 2012 Sep;130(3):751-760.e2. doi: 10.1016/j.jaci.2012.03.032. Epub 2012 May 5.

PMID:
22564682
12.

Technical advance: soluble OX40 molecule mimics regulatory T cell modulatory activity on FcεRI-dependent mast cell degranulation.

Sibilano R, Gri G, Frossi B, Tripodo C, Suzuki R, Rivera J, MacDonald AS, Pucillo CE.

J Leukoc Biol. 2011 Oct;90(4):831-8. doi: 10.1189/jlb.1210651. Epub 2011 Jun 7.

13.

Single-cell dynamics of mast cell-CD4+ CD25+ regulatory T cell interactions.

Frossi B, D'Incà F, Crivellato E, Sibilano R, Gri G, Mongillo M, Danelli L, Maggi L, Pucillo CE.

Eur J Immunol. 2011 Jul;41(7):1872-82. doi: 10.1002/eji.201041300. Epub 2011 Jun 8.

14.

Exacerbated experimental autoimmune encephalomyelitis in mast-cell-deficient Kit W-sh/W-sh mice.

Piconese S, Costanza M, Musio S, Tripodo C, Poliani PL, Gri G, Burocchi A, Pittoni P, Gorzanelli A, Colombo MP, Pedotti R.

Lab Invest. 2011 Apr;91(4):627-41. doi: 10.1038/labinvest.2011.3. Epub 2011 Feb 14.

15.

Mast cells and Th17 cells contribute to the lymphoma-associated pro-inflammatory microenvironment of angioimmunoblastic T-cell lymphoma.

Tripodo C, Gri G, Piccaluga PP, Frossi B, Guarnotta C, Piconese S, Franco G, Vetri V, Pucillo CE, Florena AM, Colombo MP, Pileri SA.

Am J Pathol. 2010 Aug;177(2):792-802. doi: 10.2353/ajpath.2010.091286. Epub 2010 Jul 1.

16.

Exploring a regulatory role for mast cells: 'MCregs'?

Frossi B, Gri G, Tripodo C, Pucillo C.

Trends Immunol. 2010 Mar;31(3):97-102. doi: 10.1016/j.it.2009.12.007. Epub 2010 Feb 10.

PMID:
20149743
17.

Mast cells enhance proliferation of B lymphocytes and drive their differentiation toward IgA-secreting plasma cells.

Merluzzi S, Frossi B, Gri G, Parusso S, Tripodo C, Pucillo C.

Blood. 2010 Apr 8;115(14):2810-7. doi: 10.1182/blood-2009-10-250126. Epub 2010 Jan 25.

18.

Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation.

Piconese S, Gri G, Tripodo C, Musio S, Gorzanelli A, Frossi B, Pedotti R, Pucillo CE, Colombo MP.

Blood. 2009 Sep 24;114(13):2639-48. doi: 10.1182/blood-2009-05-220004. Epub 2009 Jul 30.

19.

CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction.

Gri G, Piconese S, Frossi B, Manfroi V, Merluzzi S, Tripodo C, Viola A, Odom S, Rivera J, Colombo MP, Pucillo CE.

Immunity. 2008 Nov 14;29(5):771-81. doi: 10.1016/j.immuni.2008.08.018.

20.

APE/Ref-1 makes fine-tuning of CD40-induced B cell proliferation.

Merluzzi S, Gri G, Gattei V, Pagano M, Pucillo C.

Mol Immunol. 2008 Aug;45(14):3731-9. doi: 10.1016/j.molimm.2008.06.003. Epub 2008 Jul 9.

21.

Outside inside signalling in CD40-mediated B cell activation.

D'Orlando O, Gri G, Cattaruzzi G, Merluzzi S, Betto E, Gattei V, Pucillo C.

J Biol Regul Homeost Agents. 2007;21(3-4):49-62. Review.

PMID:
18261257
22.

Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers.

Bronte V, Kasic T, Gri G, Gallana K, Borsellino G, Marigo I, Battistini L, Iafrate M, Prayer-Galetti T, Pagano F, Viola A.

J Exp Med. 2005 Apr 18;201(8):1257-68. Epub 2005 Apr 11.

23.

T cell costimulation by chemokine receptors.

Molon B, Gri G, Bettella M, Gómez-Moutón C, Lanzavecchia A, Martínez-A C, Mañes S, Viola A.

Nat Immunol. 2005 May;6(5):465-71. Epub 2005 Apr 10.

PMID:
15821738
24.

CD28 and lipid rafts coordinate recruitment of Lck to the immunological synapse of human T lymphocytes.

Tavano R, Gri G, Molon B, Marinari B, Rudd CE, Tuosto L, Viola A.

J Immunol. 2004 Nov 1;173(9):5392-7.

25.

The inner side of T cell lipid rafts.

Gri G, Molon B, Manes S, Pozzan T, Viola A.

Immunol Lett. 2004 Jul 15;94(3):247-52.

PMID:
15275973
26.
27.

Antitumor effect of interleukin (IL)-12 in the absence of endogenous IFN-gamma: a role for intrinsic tumor immunogenicity and IL-15.

Gri G, Chiodoni C, Gallo E, Stoppacciaro A, Liew FY, Colombo MP.

Cancer Res. 2002 Aug 1;62(15):4390-7.

28.

Different requirements for alpha-galactosylceramide and recombinant IL-12 antitumor activity in the treatment of C-26 colon carcinoma hepatic metastases.

Chiodoni C, Stoppacciaro A, Sangaletti S, Gri G, Cappetti B, Koezuka Y, Colombo MP.

Eur J Immunol. 2001 Oct;31(10):3101-10.

PMID:
11592087
29.

Expression and function of IL-12 and IL-18 receptors on human tonsillar B cells.

Airoldi I, Gri G, Marshall JD, Corcione A, Facchetti P, Guglielmino R, Trinchieri G, Pistoia V.

J Immunol. 2000 Dec 15;165(12):6880-8.

30.

The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individuals.

Marshall JD, Chehimi J, Gri G, Kostman JR, Montaner LJ, Trinchieri G.

Blood. 1999 Aug 1;94(3):1003-11.

31.

Involvement of a p53-dependent pathway in rubella virus-induced apoptosis.

Megyeri K, Berencsi K, Halazonetis TD, Prendergast GC, Gri G, Plotkin SA, Rovera G, Gönczöl E.

Virology. 1999 Jun 20;259(1):74-84.

32.

Differentiation of human NK cells into NK1 and NK2 subsets.

Peritt D, Robertson S, Gri G, Showe L, Aste-Amezaga M, Trinchieri G.

J Immunol. 1998 Dec 1;161(11):5821-4.

33.

Positive and negative regulation of interleukin-12 gene expression.

Ma X, Riemann H, Gri G, Trinchieri G.

Eur Cytokine Netw. 1998 Sep;9(3 Suppl):54-64. Review.

PMID:
9831187
34.

Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis.

Coughlin CM, Salhany KE, Gee MS, LaTemple DC, Kotenko S, Ma X, Gri G, Wysocka M, Kim JE, Liu L, Liao F, Farber JM, Pestka S, Trinchieri G, Lee WM.

Immunity. 1998 Jul;9(1):25-34.

37.

Immunomodulatory functions and molecular regulation of IL-12.

Ma X, Aste-Amezaga M, Gri G, Gerosa F, Trinchieri G.

Chem Immunol. 1997;68:1-22. Review. No abstract available.

PMID:
9329213
38.

Interleukin-12: an immunoregulatory cytokine produced by B cells and antigen-presenting cells.

Sartori A, Ma X, Gri G, Showe L, Benjamin D, Trinchieri G.

Methods. 1997 Jan;11(1):116-27.

PMID:
8990097
40.

Earthworm leukocytes that are not phagocytic and cross-react with several human epitopes can kill human tumor cell lines.

Cossarizza A, Cooper EL, Suzuki MM, Salvioli S, Capri M, Gri G, Quaglino D, Franceschi C.

Exp Cell Res. 1996 Apr 10;224(1):174-82.

PMID:
8612683
41.

The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells.

Ma X, Chow JM, Gri G, Carra G, Gerosa F, Wolf SF, Dzialo R, Trinchieri G.

J Exp Med. 1996 Jan 1;183(1):147-57.

Supplemental Content

Support Center